Malik, M.; Radecka, B.; Gełej, M.; Jackowska, A.; Filipczyk-Cisarż, E.; Żurowska, M.; Hetman, K.; Foszczyńska-Kłoda, M.; Kania-Zembaczyńska, B.; Mańka, D.;
et al. Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil. Biomedicines 2024, 12, 2076.
https://doi.org/10.3390/biomedicines12092076
AMA Style
Malik M, Radecka B, Gełej M, Jackowska A, Filipczyk-Cisarż E, Żurowska M, Hetman K, Foszczyńska-Kłoda M, Kania-Zembaczyńska B, Mańka D,
et al. Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil. Biomedicines. 2024; 12(9):2076.
https://doi.org/10.3390/biomedicines12092076
Chicago/Turabian Style
Malik, Mateusz, Barbara Radecka, Marek Gełej, Aleksandra Jackowska, Emilia Filipczyk-Cisarż, Michalina Żurowska, Katarzyna Hetman, Małgorzata Foszczyńska-Kłoda, Beata Kania-Zembaczyńska, Danuta Mańka,
and et al. 2024. "Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil" Biomedicines 12, no. 9: 2076.
https://doi.org/10.3390/biomedicines12092076
APA Style
Malik, M., Radecka, B., Gełej, M., Jackowska, A., Filipczyk-Cisarż, E., Żurowska, M., Hetman, K., Foszczyńska-Kłoda, M., Kania-Zembaczyńska, B., Mańka, D., Orlikowska, M., & Bodnar, L.
(2024). Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil. Biomedicines, 12(9), 2076.
https://doi.org/10.3390/biomedicines12092076